X0508 4 2025-12-23 0001635088 Roivant Sciences Ltd. ROIV 0001647805 Torti Frank C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY LONDON X0 SW1H 0DB UNITED KINGDOM true President and Vant Chair false Common Shares 2025-12-23 4 A 0 175380 22.45 A 13911927 D Common Shares 2025-12-24 4 J 0 64891 22.47 D 13847036 D Common Shares 2025-12-24 4 G 0 110489 0 D 13736547 D Represents Common Shares received in exchange for shares of a subsidiary of the Issuer. The per Common Share price represents the closing price of the Issuer's Common Shares on the date of the exchange. The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $22.45 to $22.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. Represents a sale of Common Shares only to cover estimated taxes due in connection with the exchange described in footnote 1. The Reporting Person donated 110,489 Common Shares to a donor advised fund, which will use the gifted Common Shares for charitable purposes. By: /s/ Jo Chen, as Attorney-in-Fact for Frank Torti 2025-12-29